Liver Function Tests Explained: Complete Guide to LFTs | WellAlly

• Liver function tests (LFTs) are a group of blood tests that assess liver health by measuring enzymes, proteins, and waste products processed by the liver
• Despite their name, most LFTs do not directly measure liver function -- they detect liver cell damage (enzymes), bile flow problems (ALP, GGT, bilirubin), and synthetic capacity (albumin, PT/INR)
• The pattern of abnormalities across different tests helps doctors identify whether the problem is hepatocellular (liver cell damage), cholestatic (bile flow obstruction), or mixed
• Normal LFTs do not rule out all liver disease -- early cirrhosis and some liver tumors can exist with normal test results
• LFTs are used for screening, diagnosis, monitoring disease progression, and checking for medication side effects

Liver function tests, also called a liver panel or hepatic function panel, are a set of blood tests that provide information about the state of your liver. They are among the most commonly ordered blood tests in medicine, included in routine health screenings, pre-operative evaluations, and monitoring of many chronic conditions.

The name "liver function tests" is somewhat misleading. Most of the tests do not actually measure how well the liver functions. Instead, they measure:

1. Enzymes released when liver cells are damaged (ALT, AST)
2. Enzymes elevated when bile flow is impaired (ALP, GGT)
3. Waste products the liver normally clears (bilirubin)
4. Proteins the liver produces (albumin)
5. Clotting factors the liver manufactures (measured indirectly by PT/INR)

Together, these tests create a profile that helps doctors determine whether a liver problem exists, what type of problem it might be, and how severe it is.

Common reasons doctors order LFTs:

• Routine health screening (annual physical)
• Unexplained fatigue, nausea, or abdominal symptoms
• Monitoring medications known to affect the liver (statins, methotrexate, isoniazid)
• Suspected liver disease (hepatitis exposure, alcohol abuse, family history)
• Evaluating jaundice (yellowing of skin or eyes)
• Pre-operative assessment
• Monitoring known chronic liver disease
• Follow-up on abnormal imaging findings

Below is the comprehensive reference table for all components typically included in a liver panel.

ALT (Alanine Aminotransferase)

ALT is found predominantly in liver cells. When hepatocytes (liver cells) are damaged or inflamed, ALT leaks into the bloodstream. Because ALT is much more concentrated in the liver than in any other organ, an elevated ALT is the most specific indicator of liver cell injury.

Key point: ALT is considered the most reliable single marker for ongoing liver damage. Persistent ALT elevation always warrants investigation.

AST (Aspartate Aminotransferase)

AST is found in the liver, heart, skeletal muscles, kidneys, brain, and red blood cells. Elevated AST can come from any of these sources. However, when AST is elevated alongside ALT, liver injury is the most likely explanation.

The AST/ALT ratio (De Ritis ratio) is diagnostically useful:

• Ratio less than 1.0: Typical of non-alcoholic fatty liver disease and acute viral hepatitis
• Ratio greater than 1.0: Suggests alcoholic liver disease or cirrhosis
• Ratio greater than 2.0: Strongly suggests alcoholic hepatitis or cirrhosis

ALP (Alkaline Phosphatase)

ALP is found in the liver, bones, intestines, and placenta. In the liver, ALP is concentrated in the cells lining the bile ducts. When bile flow is obstructed or bile ducts are damaged, ALP rises.

Important: Elevated ALP alone could come from bone (fractures, Paget's disease, bone metastases) rather than the liver. This is why GGT is ordered alongside ALP -- if both are elevated, the source is the liver. If only ALP is elevated, the source is likely bone.

GGT (Gamma-Glutamyl Transferase)

GGT is concentrated in the bile ducts and is the most sensitive enzyme for detecting alcohol-related liver stress and drug-induced liver injury. GGT is used primarily to:

• Confirm that an elevated ALP comes from the liver (not bone)
• Screen for alcohol abuse
• Detect medication-related liver stress
• Investigate bile duct disorders

Bilirubin

Bilirubin is a yellow-orange pigment produced when old red blood cells are broken down. The liver normally processes bilirubin by conjugating it (making it water-soluble) and excreting it into bile.

Total bilirubin has two components:

• Direct (conjugated) bilirubin: Already processed by the liver; elevated levels suggest the liver can conjugate but cannot excrete (bile duct obstruction)
• Indirect (unconjugated) bilirubin: Not yet processed by the liver; elevated levels suggest either excessive red blood cell breakdown (hemolysis) or the liver cannot keep up with conjugation (Gilbert's syndrome, liver failure)

Bilirubin pattern interpretation:

Albumin

Albumin is the most abundant protein in blood plasma, produced exclusively by the liver. It maintains blood volume and transports hormones, drugs, and other substances. Albumin has a long half-life (about 20 days), so low levels suggest chronic liver disease rather than acute injury.

Low albumin causes:

• Chronic liver disease (cirrhosis, liver failure)
• Malnutrition or malabsorption
• Kidney disease (nephrotic syndrome -- albumin lost in urine)
• Severe inflammation or infection
• Protein-losing enteropathy (intestinal protein loss)

PT/INR (Prothrombin Time)

The liver produces most of the clotting factors in your blood. Prothrombin time measures how long it takes blood to clot. When the liver cannot produce enough clotting factors, PT prolongs and INR rises. Because clotting factors have short half-lives (hours to days), PT/INR is an excellent real-time measure of liver synthetic function.

Elevated INR causes:

• Acute liver failure
• Decompensated cirrhosis
• Vitamin K deficiency (vitamin K is needed for clotting factor synthesis)
• Warfarin (blood thinner) therapy
• Disseminated intravascular coagulation (DIC)

Hepatocellular Pattern (ALT/AST Predominant)

Cholestatic Pattern (ALP/GGT Predominant)

Mixed Pattern

Both hepatocellular and cholestatic enzyme elevations can occur simultaneously in chronic liver disease, metastatic cancer, and granulomatous diseases (sarcoidosis, tuberculosis).

Fasting: A 10-12 hour fast is typically recommended when a complete liver panel is ordered. Water is permitted. Fasting is especially important if glucose and lipid levels are being measured alongside LFTs.

Medications: Continue all prescribed medications unless your doctor specifically instructs you to stop. Bring a complete list of medications, supplements, and herbal products to your appointment.

Alcohol: Avoid alcohol for at least 48 hours before testing to prevent false elevations, particularly of GGT.

Exercise: Avoid vigorous exercise for 24-48 hours before testing, as it can elevate AST.

Food and timing: Schedule your blood draw in the morning if possible. Some components (particularly bilirubin) can show minor diurnal variation.

Step-by-Step Interpretation

Step 1: Identify the pattern. Look at which tests are abnormal.

• ALT/AST elevated more than ALP = hepatocellular pattern
• ALP/GGT elevated more than ALT/AST = cholestatic pattern
• Both patterns present = mixed

Step 2: Assess severity. How many times above the upper limit of normal are the values?

Step 3: Check synthetic function. Are albumin and PT/INR normal? If not, the liver's ability to produce proteins is compromised, which suggests more advanced disease.

Step 4: Evaluate bilirubin. Is total bilirubin elevated? If so, is it direct or indirect predominant?

Step 5: Consider clinical context. Age, sex, medications, alcohol use, symptoms, and medical history all factor into interpretation.

Common Results Scenarios

Scenario 1: Mild ALT/AST elevation (1-3x ULN), everything else normal

• Most common finding in routine screening
• Usually represents fatty liver, medication effect, or mild alcohol use
• Repeat in 4-8 weeks after addressing modifiable factors

Scenario 2: Very high ALT/AST (>1000 U/L), normal ALP

• Suggests acute liver injury
• Causes: acute viral hepatitis, ischemic hepatitis, drug-induced injury (acetaminophen overdose), autoimmune flare
• Requires urgent evaluation

Scenario 3: Elevated ALP and GGT, normal ALT/AST

• Bile duct problem
• Requires imaging (ultrasound first, then MRCP or CT if needed)
• Consider gallstones, PBC, PSC, or tumor

Scenario 4: All tests normal but clinical suspicion for liver disease

• Early cirrhosis can have normal LFTs
• Consider FibroScan, liver ultrasound, or referral to hepatologist

For Fatty Liver Disease (NAFLD)

• Weight loss: 5-10% of body weight reduces liver fat and inflammation
• Diet: Mediterranean pattern with reduced sugar, refined carbs, and saturated fat
• Exercise: 150+ minutes per week of moderate-intensity aerobic activity
• Control blood sugar, blood pressure, and cholesterol
• Avoid alcohol
• No FDA-approved medications specifically for NAFLD yet (vitamin E and pioglitazone may be considered)

For Viral Hepatitis

For Alcoholic Liver Disease

• Complete alcohol cessation (most critical intervention)
• Nutritional support (thiamine, folate, multivitamins)
• Corticosteroids for severe alcoholic hepatitis (Maddrey's discriminant function > 32)
• Liver transplant evaluation for end-stage disease (requires 6 months of documented sobriety at most centers)

For Bile Duct Obstruction

• ERCP for gallstone removal or stent placement
• Surgical evaluation for tumors
• Ursodeoxycholic acid (UDCA) for primary biliary cholangitis
• Antibiotics if infection is present

For Autoimmune Hepatitis

• Corticosteroids (prednisone) for induction
• Azathioprine or mycophenolate for maintenance
• Long-term immunosuppression typically required
• Liver transplant for end-stage disease

Seek Emergency Care For

• Sudden onset of jaundice with confusion (acute liver failure)
• Vomiting blood or passing black, tarry stools
• Severe right upper abdominal pain with fever
• Rapid abdominal swelling (ascites)
• Marked drowsiness, confusion, or personality changes (hepatic encephalopathy)
• Very high liver enzymes (ALT or AST above 1000 U/L)

Schedule a Routine Visit For

• Mildly abnormal LFTs found on routine screening
• Persistent fatigue, nausea, or right upper abdominal discomfort
• Planning to start medications known to affect the liver
• Family history of liver disease
• Heavy alcohol use (discuss screening and support)
• Unexplained weight loss or loss of appetite

Routine Screening Recommendations

• Annual LFTs for patients on statins, methotrexate, or other hepatotoxic medications
• One-time hepatitis C screening for all adults born 1945-1965
• LFTs every 6-12 months for patients with known chronic liver disease
• LFTs as part of annual physical for patients with obesity, diabetes, or metabolic syndrome
• Baseline LFTs before starting any new long-term medication

Can I have liver disease with normal liver function tests?

Yes. This is an important limitation of LFTs. Early compensated cirrhosis, small liver tumors, and mild chronic hepatitis can all exist with entirely normal liver enzyme levels. LFTs measure ongoing damage or dysfunction, not the total amount of scar tissue or the presence of tumors. If liver disease is suspected despite normal LFTs, your doctor should order imaging (ultrasound, FibroScan, or MRI) for a complete evaluation.

How often should liver function tests be repeated if they are abnormal?

The follow-up interval depends on the degree of abnormality. Mildly elevated enzymes (less than 2 times the upper limit of normal) are typically rechecked in 4-8 weeks after addressing potential causes (alcohol, medications, fatty diet). Moderately elevated enzymes (2-5 times ULN) should be rechecked sooner, usually in 2-4 weeks, and may warrant simultaneous workup including hepatitis panels and imaging. Severely elevated enzymes require urgent evaluation, often within days.

Do all medications that elevate liver enzymes need to be stopped?

Not necessarily. Mild enzyme elevations (up to 3 times the upper limit of normal) are acceptable for many medications and do not automatically require discontinuation. For example, statins commonly cause mild ALT elevations that are not dangerous. The decision to continue, adjust, or stop a medication depends on the specific drug, the degree of enzyme elevation, the availability of alternatives, and the importance of the medication for your overall health. This decision should always be made by your prescribing doctor.

What is the difference between a liver panel and a comprehensive metabolic panel (CMP)?

A CMP includes the liver panel tests (ALT, AST, ALP, bilirubin, albumin, total protein) plus kidney function tests (creatinine, BUN), electrolytes (sodium, potassium, chloride, CO2), blood sugar (glucose), and calcium. Your doctor may order a CMP instead of a standalone liver panel if they want to assess multiple organ systems simultaneously. The liver information in both tests is the same.

Can liver function tests detect liver cancer?

LFTs are not a screening test for liver cancer. They may be abnormal in advanced liver cancer, but early-stage hepatocellular carcinoma (HCC) often does not cause enzyme elevations. Patients at risk for liver cancer (those with cirrhosis, chronic hepatitis B or C) should be screened with liver ultrasound every 6 months, sometimes combined with alpha-fetoprotein (AFP) blood testing. LFTs play a role in assessing overall liver health but not in directly detecting tumors.

Why do my liver enzymes fluctuate from test to test?

Mild fluctuations in liver enzymes are normal and occur for many reasons: recent illness, exercise intensity, dietary changes, alcohol consumption, medication timing, and even the time of day the blood is drawn. Minor variations (10-20%) between tests are generally not concerning. What matters more is the overall trend over multiple tests. Your doctor looks at patterns rather than focusing on a single number.